Humana Inc. (NYSE:HUM) Shares Sold by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. lowered its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,673 shares of the insurance provider's stock after selling 4,693 shares during the quarter. Nomura Asset Management Co. Ltd.'s holdings in Humana were worth $9,304,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Pinnacle Wealth Management Advisory Group LLC increased its stake in Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock valued at $272,000 after purchasing an additional 37 shares in the last quarter. Atlas Brown Inc. raised its stake in Humana by 0.6% in the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock worth $1,611,000 after acquiring an additional 38 shares during the last quarter. Mather Group LLC. grew its stake in Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after purchasing an additional 41 shares during the last quarter. Capital Advisors Ltd. LLC increased its holdings in shares of Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock valued at $53,000 after purchasing an additional 43 shares during the period. Finally, Retirement Planning Co of New England Inc. raised its stake in shares of Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after purchasing an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Remove Ads

Humana Price Performance

HUM traded down $1.13 on Thursday, reaching $264.67. 1,808,672 shares of the company's stock were exchanged, compared to its average volume of 1,722,925. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The stock has a market cap of $31.94 billion, a PE ratio of 26.60, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock's fifty day moving average price is $268.97 and its 200-day moving average price is $272.62.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana's dividend payout ratio is presently 35.58%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Truist Financial raised their target price on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a report on Monday, January 6th. JPMorgan Chase & Co. lowered their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Eighteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.